Please find enclosed herewith the Notice of 41st AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Wednesday, July 15, 2026, at 11:00 A.M. (IST) through VC/OAVM. The ....

June 23, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Sub: Notice of the 41st Annual General Meeting (41st AGM) of Bliss GVS Pharma Limited Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 41st AGM of Bliss GVS Pharma Limited (“the Company”) scheduled to be held on Wednesday, July 15, 2026, at 11:00 a.m. (IST) through Video Conference/Other Audio-Visual Means. The said Notice forms part of the Company's Annual Report for the financial year 2025-2026. The Notice of the 41st AGM and the Annual Report for the financial year 2025-2026 are available on the Company's website at https://www.blissgvs.com/annual-reports. The Annual Report contains the information to be given, and disclosures required to be made in terms of Regulation 34(2) and 34(3) of the SEBI Listing Regulations In accordance with Regulation 42 of the SEBI Listing Regulations, kindly note that the Company has fixed Wednesday, July 08, 2026, as the Record Date for determining entitlement of members to the final dividend for financial year ended March 31, 2026 and the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, July 09, 2026, to Wednesday, July 15, 2026 (both the days inclusive). If the final dividend, as recommended by the Board of Directors, is approved at the 41st AGM by the shareholders, payment of such dividend, subject to deduction of tax at source, will be made on or before Friday, August 14, 2026. This is for your information and records. Thanking you. Yours faithfully, For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary and Compliance Officer Encl: As above Notice Notice NOTICE IS HEREBY GIVEN THAT THE 41ST (FORTY FIRST) ANNUAL GENERAL MEETING (‘AGM’) OF THE MEMBERS OF BLISS GVS PHARMA LIMITED WILL BE HELD ON WEDNESDAY, JULY 15, 2026, AT 11:00 AM THROUGH VIDEO CONFERENCING (“VC”)/OTHER AUDIO-VISUAL MEANS (“OVAM”) TO TRANSACT THE FOLLOWING BUSINESS. THE VENUE OF THE MEETING SHALL BE DEEMED TO BE THE REGISTERED OFFICE OF THE COMPANY SITUATED AT 102, HYDE PARK, SAKI VIHAR ROAD, ANDHERI (EAST), MUMBAI-400 072, MAHARASHTRA, INDIA. ORDINARY BUSINESS: To appoint a director in place of Mr. Narsimha Shibroor Kamath (DIN: 00140593), who retires by rotation and, 1. Adoption of Financial Statements for the financial being eligible, offers himself for re-appointment. year ended March 31, 2026: To receive, consider, and adopt the Audited Standalone By order of the Board of Directors Financial Statements for the year ended March 31, For BLISS GVS PHARMA LIMITED 2026, together with the Reports of the Board of Directors and the Auditors thereon and the Audited Sd/- Consolidated Financial Statements for the year ended Narsimha Shibroor Kamath March 31, 2026, and the reports of auditors thereon. Managing Director & CEO DIN: 00140593 2. Declaration of Final Dividend on Equity Shares for Place: Mumbai the Financial Year ended March 31, 2026: Date: May 12, 2026 To consider and declare Final Dividend of 100% i.e. H 1.00 per equity share on face value of H 1/- each Registered Office: for the financial year ended March 31, 2026, as 102, Hyde Park, Saki Vihar Road, recommended by the Board. Andheri - East, Mumbai - 400072 CIN: L24230MH1984PLC034771 3. Re-Appointment of Mr. Narsimha Shibroor Website: www.blissgvs.com Kamath (DIN: 00140593) as a Managing Director E-mail : info@blissgvs.com & CEO, liable to retire by rotation, who has offered Tel : +91 22 42160000 himself for re-appointment. Fax: +91 22 28563930 NOTES: provisions of the Companies Act, 2013 (“Act”) and the SEBI (Listing Obligations and Disclosure Requirements) 1. Pursuant to General Circular No.14/2020 dated April Regulations, 2015 (“Listing Regulations/SEBI Listing 08, 2020, General Circular No. 17/2020 dated April Regulations”), the 41st Annual General Meeting 13, 2020, Circular No. 20/2020 dated May 05, 2020, (‘41st AGM/AGM’) of the Company is being conducted Circular No. 02/2021 dated January 13, 2021, Circular through VC / OAVM Facility, which does not require No. 19/2021 dated December 8, 2021, Circular No. physical presence of members at a common venue. The 21/2021 dated December 14, 2021, Circular No. deemed venue for the 41st AGM shall be the Registered 02/2022 dated May 5, 2022, General Circular No. Office of the Company. 10/2022 dated December 28, 2022, General Circular No. 09/2023 dated September 25, 2023 and General 2. Pursuant to the provisions of Section 108 of the Circular No. 09/2024 dated September 19, 2024, Companies Act, 2013, read with Rule 20 of the and General Circular No. 03/2025 dated September Companies (Management and Administration) Rules, 22, 2025, issued by the Ministry of Corporate Affairs 2014, Regulation 44 of Listing Regulations, as may (“MCA Circulars”) Circular No. SEBI/HO/CFD/ be amended, and MCA Circulars, the Company is CMD1/CIR/P/2020/79 dated May 12, 2020, Circular providing the facility of remote e-voting to its Members No. SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated in respect of the business to be transacted at the January 15, 2021, Circular SEBI/HO/CFD/CMD2/ 41st AGM. For this purpose, the Company has entered CIR/P/2022/62 dated May 13, 2022, Circular SEBI/ into an agreement with Central Depository Services HO/CFD/PoD-2/ P/CIR/2023/4 dated January 05, (India) Limited (‘CDSL’) for facilitating voting through 2023, Circular SEBI/HO/DDHS/P/CIR/2023/0167 electronic means, as the authorized e-Voting’s agency. dated October 07, 2023 and Circular No. SEBI/HO/ The facility of casting votes by a member using remote CFD/CFD-PoD-2/P/CIR/2024/133 dated October 03, e-voting, participation in the AGM through VC/OAVM 2024 issued by the Securities and Exchange Board of and the e-voting system on the date of the 41st AGM India (“SEBI Circulars”) and in compliance with the will be provided by CDSL. 3. For convenience of the members and proper conduct Company or the Depository Participant(s) as on June of the AGM, Members can login and join the AGM in 12, 2026. Members may note that the Notice and the VC/OAVM mode at least 30 (thirty) minutes before Annual Report 2025-2026 can also be accessed from the time scheduled for the commencement of the the website of the Company at https://www.blissgvs. Meeting by following the procedure mentioned below. com/ and on websites of the Stock Exchanges, i.e. BSE The facility of participation at the AGM through VC/ Limited at https://www.bseindia.com/ and National OAVM will be made available to at least 1000 members Stock Exchange of India Limited at https://www. on a first-come, first-served basis. This will not include nseindia.com/ The AGM Notice is also disseminated on large Shareholders (Shareholders holding 2% or more the website of CDSL (agency for providing the Remote shareholding), Promoters, Institutional Investors, e-Voting facility and e-voting system during the AGM) Directors, Key Managerial Personnel, the Chairpersons i.e. www.evotingindia.com. Interested Members can of the Audit Committee, Nomination and Remuneration write to the company at info@blissgvs.com/cs@ Committee and Stakeholders Relationship Committee, blissgvs.com for a hard copy of the Annual Report for Auditors, etc., who are allowed to attend the the financial year 2025-2026. AGM without restriction on account of first-come, 7. The Certificate of M/s. AVS & Associates, Secretarial first-served basis. Auditors of the Company confirming implementation 4. The attendance of the Members attending the AGM of Bliss GVS Pharma Limited - Employee Stock Options through VC/OAVM will be counted for the purpose Plan, 2019 in accordance with the provisions [Showing first 8,000 characters — download PDF for full document]